drugset / Trial / NCT06784843

Dexmedetomidine Versus Midazolam for Peribulbar Block

NCT06784843 ↗

Completed 50 enrolled Suez Canal University
RandomizedParallel-groupDouble-blindTreatment

Summary

50 patients of both sexes, ages 18 to 75, who were scheduled for cataract surgery and had physical status I or II according to the American Society of Anesthesiologists were included in this study. After induction of general anesthesia, all patients received peribulbar block. In group A (midazolam group), 25 patients received midazolam. In group B (dexmedetomidine group), 25 patients received dexmedetomidine.

Timeline

Start
2023-12-01
Primary completion
2024-08-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 50 ug —
Comparator Midazolam Small molecule 1 mg —

Indications